The Effect of Reality therapy on the Level of Anxiety, Stress, Depression and Cortisol in Pregnant Mothers in anticipation of Amniocentesis

The Effect of Reality therapy on the Level of Anxiety, Stress, Depression and Cortisol in Pregnant Mothers in anticipation of Amniocentesis in Isfahan ?2019

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190423043351N1

Enrollment

Registered

2019-08-09

Start date

2019-06-22

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Stress. Condition 2: . Condition 3: . Condition 4: Anxiety. Condition 5: Depression. Acute stress reaction Anxiety disorder due to known physiological condition Neonatal cerebral depression

Interventions

Intervention 1: Intervention group: Individuals in groups of 2 to 10 will participate in reality therapy counseling sessions, which consist of 4 sessions, which will last 90 to 120 minutes. In the fir

Eligibility

Sex/Gender

Female

Age

15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Age between 49-15 years Pregnancy Carry out an amniocentesis test Readiness and satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Underlying diseases Neurological and neurological diseases Drug abuse

Design outcomes

Primary

Measure	Time frame
Score stress Stress score in DOS 21questionnaire. Timepoint: First and last meeting. Method of measurement: DOS 21 questionnaire.;Anxiety score in the DOS21 questionnaire. Timepoint: First and last meeting. Method of measurement: DOS21 questionnaire.;DOS21 questionnaire. Timepoint: First and last meeting. Method of measurement: DOS21 questionnaire.;Blood cortisol levels. Timepoint: First and last meeting. Method of measurement: blood test.	—

Measure

Time frame

Score stress Stress score in DOS 21questionnaire. Timepoint: First and last meeting. Method of measurement: DOS 21 questionnaire.;Anxiety score in the DOS21 questionnaire. Timepoint: First and last meeting. Method of measurement: DOS21 questionnaire.;DOS21 questionnaire. Timepoint: First and last meeting. Method of measurement: DOS21 questionnaire.;Blood cortisol levels. Timepoint: First and last meeting. Method of measurement: blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Ghaderi NajafAbadi

Kerman University of Medical Sciences

m_ghadere@yahoo.com+98 31 3627 7989

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026